Acurx Pharmaceuticals (ACXP) Institutional Ownership $0.43 +0.01 (+2.38%) As of 04/30/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Acurx Pharmaceuticals (NASDAQ:ACXP)CurrentInstitutional OwnershipPercentage11.53%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$144.01KNumber ofInstitutional Sellers(last 12 months)0 Get ACXP Insider Trade Alerts Want to know when executives and insiders are buying or selling Acurx Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ACXP Institutional Buying and Selling by Quarter Acurx Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/11/2025 Vanguard Capital Wealth Advisors67,500$26K0.0%N/A0.301% 4/11/2025 Prospect Financial Services LLC366,576$143K0.1%+11.4%1.637% 1/22/2025 Prospect Financial Services LLC329,076$268K0.1%+11.5%1.932% 11/16/2024Geode Capital Management LLC146,500$278K0.0%+12.7%0.902% 10/15/2024 Prospect Financial Services LLC295,075$561K0.3%+6.1%1.862% 7/15/2024 Prospect Financial Services LLC278,100$626K0.5%+1.9%1.756% 4/23/2024 Prospect Financial Services LLC272,850$668K0.6%+6.9%1.732% 4/5/2024 NBC Securities Inc.14,000$34K0.0%N/A0.089% 2/20/2024 Prospect Financial Services LLC255,150$977K1.0%N/A1.853% 2/1/2024Sigma Planning Corp10,000$38K0.0%N/A0.073% 11/15/2023Armistice Capital LLC500,000$750K0.0%-57.7%3.843% 8/14/2023One68 Global Capital LLC13,044$35K0.2%N/A0.101% 11/14/2022Armistice Capital LLC1,066,000$3.20M0.1%N/A9.224% 8/12/2022Semmax Financial Advisors Inc.5,879$28K0.0%+365.5%0.057% 8/1/2022 Castle Wealth Management LLC13,000$49K0.0%N/A0.127% 1/10/2022 Patriot Financial Group Insurance Agency LLC7,000$30K0.0%+75.0%0.069% 11/15/2021Tocqueville Asset Management L.P.19,100$98K0.0%+91.0%0.189% 11/9/2021BlackRock Inc.6,515$33K0.0%N/A0.064% 8/16/2021Tocqueville Asset Management L.P.10,000$64K0.0%N/A0.105% (Data available from 1/1/2016 forward) ACXP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ACXP shares? During the previous two years, the following institutional investors and hedge funds held shares of Acurx Pharmaceuticals shares: Armistice Capital LLC ($750K), Geode Capital Management LLC ($278K), Prospect Financial Services LLC ($143K), Sigma Planning Corp ($38K), One68 Global Capital LLC ($35K), and NBC Securities Inc. ($34K), and Vanguard Capital Wealth Advisors ($26K).Learn more on ACXP's institutional investors. What percentage of Acurx Pharmaceuticals stock is owned by institutional investors? 11.53% of Acurx Pharmaceuticals stock is owned by institutional investors. Learn more on ACXP's institutional investor holdings. Which institutional investors have been buying Acurx Pharmaceuticals stock? The following institutional investors have purchased Acurx Pharmaceuticals stock in the last 24 months: Prospect Financial Services LLC ($366.58K), Vanguard Capital Wealth Advisors ($67.50K), Geode Capital Management LLC ($16.49K), NBC Securities Inc. ($14K), One68 Global Capital LLC ($13.04K), and Sigma Planning Corp ($10K). How much institutional buying is happening at Acurx Pharmaceuticals? Institutional investors have bought a total of 487,605 shares in the last 24 months. This purchase volume represents approximately $1.27M in transactions. Which Acurx Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Acurx Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($682K). How much institutional selling is happening at Acurx Pharmaceuticals? Institutional investors have sold a total of 682,000 shares in the last 24 months. This volume of shares sold represents approximately $1.02M in transactions. Related Companies X4 Pharmaceuticals Major Shareholders Scilex Major Shareholders OS Therapies Major Shareholders NRx Pharmaceuticals Major Shareholders Surrozen Major Shareholders Alterity Therapeutics Major Shareholders Cadrenal Therapeutics Major Shareholders Pluri Major Shareholders Marinus Pharmaceuticals Major Shareholders Kezar Life Sciences Major Shareholders This page (NASDAQ:ACXP) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acurx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acurx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ACXP Stock Free ACXP Stock Alerts